Cel­gene prices $4.5B se­nior notes to help buy Juno; Health Af­fairs study says No­var­tis prices its CAR-T too high

→ Cel­gene $CELG has priced four se­ries of se­nior un­se­cured notes for an ag­gre­gate of $4.5 bil­lion, a por­tion of which will be used to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA